You have 9 free searches left this month | to do more

Temozolomide

Temozolomide is a drug used to treat Glioblastoma, Brain and Central Nervous System Tumors, Glioblastoma Multiforme, and other conditions. Temozolomide is being actively studied in 181 studies and prior, has been studied in 272.

Top SponsorsTop SitesTop Investigators
National Cancer Institute (NCI)Dana-Farber Cancer InstituteGary Archer Ph.D.
M.D. Anderson Cancer CenterWashington University School of MedicinePatrick Y. Wen, MD
Merck Sharp & Dohme Corp.Children's Hospital of PhiladelphiaZhongping Chen
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Recruiting
  • Adenocarcinoma - GEJ
  • Cancer of Esophagus
  • Temozolomide
  • +3 more
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
2021-10-06
Oct 6, 2021
W
Terminated
  • Recurrent Pituitary Adenomas
  • New York, New York
    Weill Cornell Medical College
2021-12-21
Dec 21, 2021
A
Not yet recruiting
  • Breast Cancer Triple Negative
  • (no location specified)
2021-11-17
Nov 17, 2021
B
Completed
  • Glioblastoma Multiforme
  • +2 more
  • Nanoliposomal Irinotecan
  • Temozolomide
  • Providence, Rhode Island
    Rhode Island Hospital
2022-02-01
Feb 1, 2022
S
Completed
  • Glioblastoma Multiforme
  • Temozolomide
  • Washington, District of Columbia
  • +2 more
2021-11-17
Nov 17, 2021
U
Recruiting
  • Glioblastoma
  • Hypofractionated radiotherapy
  • Temozolomide
  • Louisville, Kentucky
    James Graham Brown Cancer Center
2021-10-22
Oct 22, 2021
V
Completed
  • Malignant Glioma
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
2022-03-09
Mar 9, 2022
C
Recruiting
  • Glioma
  • Glioblastoma
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
2022-01-24
Jan 24, 2022
U
Recruiting
  • Glioblastoma
  • Dose-Intensified Radiotherapy
  • +2 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
2021-12-16
Dec 16, 2021
W
Active, not recruiting
  • Glioma
  • Glioblastoma Multiforme
  • Temozolomide
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-02-25
Feb 25, 2022
Y
Not yet recruiting
  • Melanoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
2021-11-01
Nov 1, 2021
M
Active, not recruiting
  • Glioblastoma
  • Temozolomide
  • +2 more
  • Boston, Massachusetts
  • +1 more
2021-10-27
Oct 27, 2021
U
Active, not recruiting
  • Neuroblastoma
  • Vienna, Austria
  • +9 more
2022-02-14
Feb 14, 2022
U
Active, not recruiting
  • Neuroendocrine Tumors
  • +3 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
2021-10-29
Oct 29, 2021
A
Not yet recruiting
  • Metastatic Pancreatic Neuroendocrine Tumor
  • Unresectable Pancreatic Neuroendocrine Carcinoma
  • Lutetium Lu 177 Dotatate
  • +4 more
  • (no location specified)
2022-02-10
Feb 10, 2022
N
Recruiting
  • Glioblastoma Multiforme (GBM)
  • +8 more
  • New York, New York
    Lenox Hill Brain Tumor Center
2021-08-30
Aug 30, 2021
S
Not yet recruiting
  • Glioblastoma Multiforme
  • Baltimore, Maryland
    Johns Hopkins Medical Institution
2022-02-14
Feb 14, 2022
N
Recruiting
  • Carcinoma, Small Cell
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
W
Recruiting
  • Glioblastoma Multiforme
  • Saint Louis, Missouri
    Washington University School of Medicine
2022-03-02
Mar 2, 2022
S
Recruiting
  • Glioblastoma Multiforme
  • Temozolomide
  • +2 more
  • Washington, District of Columbia
  • +2 more
2021-09-17
Sep 17, 2021
U
Recruiting
  • Malignant Glioma of Brain
  • Chicago, Illinois
    University of Chicago Medical Center
2022-04-01
Apr 1, 2022
U
Terminated
  • Low Grade Glioma
  • +3 more
  • San Francisco, California
    University of California, San Francisco
2021-11-03
Nov 3, 2021
Z
Active, not recruiting
  • Small Cell Lung Cancer
  • Boston, Massachusetts
  • +2 more
2022-01-24
Jan 24, 2022
N
Recruiting
  • Gliosarcoma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022